Column Group’s Surrozen SRZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.7M Hold
1,916,950
56.46% 1
2026
Q1
$55.8M Buy
1,916,950
+65,600
+4% +$1.57M 55.45% 1
2025
Q4
$41.8M Buy
1,851,350
+351,577
+23% +$5.69M 50.54% 1
2025
Q3
$19.3M Hold
1,499,773
23.88% 2
2025
Q2
$13.4M Hold
1,499,773
20.4% 2
2025
Q1
$17.5M Buy
1,499,773
+689,685
+85% +$8.02M 39.54% 2
2024
Q4
$11.6M Hold
810,088
20.85% 3
2024
Q3
$9.7M Hold
810,088
13.95% 3
2024
Q2
$8.87M Buy
810,088
+193,548
+31% +$2M 12.44% 3
2024
Q1
$9.69M Sell
616,540
-11,111
-2% -$124K 6.03% 5
2023
Q4
$5.9M Sell
627,651
-2
-0% -$14 3.9% 5
2023
Q3
$4.61M Hold
627,653
3.06% 6
2023
Q2
$5.18M Buy
627,653
+11,111
+2% +$104K 2.01% 6
2023
Q1
$5.57M Sell
616,542
-11,111
-2% -$135K 2.01% 6
2022
Q4
$5.48M Buy
627,653
+11,111
+2% +$235K 1.82% 6
2022
Q3
$18.7M Hold
616,542
4.13% 5
2022
Q2
$27.7M Sell
616,542
-11,111
-2% -$454K 5.9% 5
2022
Q1
$28.3M Hold
627,653
5.25% 5
2021
Q4
$60.6M Buy
627,653
+11,111
+2% +$1.26M 8.25% 4
2021
Q3
$65.5M Buy
+616,542
New +$86.8M 7.45% 5

Other funds holding SRZN

Column Group's SRZN Position: Q2 2026 in Review

Column Group held its Surrozen (SRZN) position steady in Q2 2026 at 1,916,950 shares worth $49.7M. The position accounts for 56.46% of the portfolio, ranked #1.

Column Group first reported a position in SRZN in Q3 2021 and has held it in 20 quarters since. The position peaked at $65.5M in Q3 2021. 61 funds tracked by Wall St. Rank hold SRZN as of Q2 2026.

  • Column Group held 1,916,950 shares of Surrozen worth $49.7M as of Q2 2026.
  • Column Group left its Surrozen share count unchanged in Q2 2026.
  • Surrozen made up 56.46% of Column Group's portfolio in Q2 2026, its #1 holding.
  • Column Group first reported a position in Surrozen in Q3 2021 and has held it in 20 quarters since.
  • Column Group's Surrozen position peaked at $65.5M in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Surrozen as of Q2 2026.

Based on Column Group's 13F filing for Q2 2026, filed 14 Aug 2026.